Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Share Name	Share Symbol	Market	Type
Nano X Imaging Ltd	NASDAQ:NNOX	NASDAQ	Common Stock

Share Name

Share Symbol

Market

Type

Nano X Imaging Ltd

NASDAQ:NNOX

NASDAQ

Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.12	-1.69%	6.96	6.96	7.00				30,015	13:03:30

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

-0.12

-1.69%

6.96

7.00

30,015

13:03:30

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23/09/2024 2:16pm

Edgar (US Regulatory)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2024

Commission File Number: 001-39461

NANO-X IMAGING LTD

Ofer Tech Park

94 Shlomo Shmeltzer Road

Petach Tikva

Israel 4970602

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

CONTENTS

On Friday 20, 2024, Nano-X Imaging Ltd. (the “Company”) held an Analyst Day, during which the Company presented recent commercial, clinical and regulatory pathways, and provided a glance to its future products which are in development stages and are not yet regulatory cleared. A copy of the presentation, excluding a VR demo, is attached hereto as Exhibit 99.1 and incorporated herein by reference.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NANO-X IMAGING LTD (Registrant)

Date: September 23, 2024	By:	/s/ Ran Daniel
		Ran Daniel
		Chief Financial Officer

Exhibit 99.1

Nanox Analyst Day 2024 and its subsidiaries

Nanox Analyst Day 2024

Cantor Global Healthcare Conference

Nanox Analyst Day 2024

Nanox Analyst Day 2024 • • • • • •

Nanox Analyst Day 2024 Chest 30% Hand 29% Head 5% Pelvis 4% Leg 13% Abdomen 6% Spine 13%

Nanox Analyst Day 2024 Sherri Donaldson, COO at DRI, Kansas Dr. Todd Goldman, Chiropractor at TCC, New York

Nanox Analyst Day 2024 U.S. FDA 510(k)

Nanox Analyst Day 2024 Alexis Kurek, PhD. MA.CCC - SLP Population Health Operations Specialist Dr. Madubata, MD Non - Invasive Cardiologist Einstein Medical Center, Philadelphia Brittany Weber,MD Phd. Director, Cardio - Rheumatology Clinic, Division of Preventive Cardiology, Division of Cardiovascular Imaging

Nanox Analyst Day 2024 Radiologists Radiologists + AI tool

Nanox Analyst Day 2024 Early findings study, show in the ADOPT that Nanox.AI software improves the detection of spine fractures, an early sign of osteoporosis, outperforming UK National Health Service national average . ”

Nanox Analyst Day 2024

Nanox Analyst Day 2024 Pulmonary nodule is expected to be the first AI application for the new Nanox.ARC X, automatically identifying patients with pulmonary nodules aiming to raise report rates across US